All In MedTech

FDA Clearance Tracker · P020025-S141

INTELLAGEN™ Cardiac Ablation System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 17, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 17, 2024

Approved

Time to decision

369 days

Received Jul 14, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P020025-S141
Device name
INTELLAGEN™ Cardiac Ablation System
Applicant location
St Paul, MN
Received
Jul 14, 2023
Decided
Jul 17, 2024
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P020025

Device type

Device class
Class III

Every decision under product code OAD

FDA's approval statement

As written in FDA's record.

an alternate and compatible radiofrequency (RF) generator, remote control, irrigation pump, tubing set, and foot pedal referred to collectively as the INTELLAGEN™ Cardiac Ablation System (INTELLAGEN)

Source documents

Other decisions for Boston Scientific

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.